Body composition and mortality in chronic obstructive pulmonary disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index; 1 of the 47 sources its claims cite were checked for support.
Overview
CoChat Summary
TL;DR
In 412 patients with moderate-to-severe COPD, fat-free mass index independently predicted all-cause mortality, whereas fat mass index did not. Low fat-free mass categories (cachexia and muscle atrophy) had worse survival than no impairment, supporting body-composition assessment as a systemic marker in COPD staging.
Key findings
- During a maximum follow-up of 5 y (mean 48 ± 20 mo), 46% of patients (n = 189) died.
- After adjustment for age, sex, FEV₁, IVC, PaCO₂, and PaO₂, fat-free mass index was an independent predictor of mortality (RR: 0.90; 95% CI: 0.84, 0.96; P = 0.003), but fat mass index was not (RR: 1.02; 95% CI: 0.95, 1.09; P = 0.680).
- Median survival was significantly worse in cachexia (26 mo; 95% CI: 21, 31 mo) and muscle atrophy (24 mo; 95% CI: 15, 33 mo) than in semistarvation (36 mo; 95% CI: 28, 44 mo) or no impairment (47 mo; 95% CI: 37, 57 mo) (P < 0.001).
- Cachexia was significantly more prevalent in GOLD stage IV than in GOLD stages II and III (P = 0.001); by SMI criteria, 51% of the total population was at moderate and 31% at high risk of physical disability.
Methods
- Cohort study of 412 clinically stable COPD patients (GOLD stages II–IV; FEV₁ 36 ± 14% of predicted, range 19–70%) screened for admission to a clinical pulmonary rehabilitation program between 1 January 1988 and 30 December 1991; mortality was assessed on 31 January 1993, with follow-up of 2–5 y or until death.
- Body composition was assessed by single-frequency bioelectrical impedance (50 Hz); fat-free mass was calculated with disease-specific equations, fat mass as body weight minus fat-free mass, and FFMI, FMI, and SMI were calculated and compared with reference values. Patients were stratified into cachexia, semistarvation, muscle atrophy, or no impairment by BMI and FFMI cutoffs.
- Main analysis used Kaplan-Meier survival curves, log-rank tests, and Cox proportional hazards models, unadjusted and adjusted for age, sex, disease severity (FEV₁, IVC, PaO₂, PaCO₂), and GOLD classification; P < 0.05 was considered significant.
Limitations
- Stated in the paper: the study population was skewed toward more males and more severe GOLD stages III and IV, and the semistarvation and muscle atrophy categories were relatively small.
- Stated in the paper: smoking status was not objectively verified (e.g., by cotinine measurements), and because smoking was not associated with mortality in these subjects, the reported models excluded smoking.
- Evident from the text: body composition was measured only at baseline, so the sequence of body-composition changes could not be established; emphysema severity was not adjusted for despite being discussed as potentially relevant; and the cohort was selected from rehabilitation screening in the southern Netherlands, which may limit generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 27 Not checked · 36 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“These studies all indicate that BIA may be a useful clinical screening instrument for characterization of the tissue-depletion pattern in chronic lung disease.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
What the sources say
- Not checked yetcites [12] Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol 2000;89:465-71. source
Checked before — its earlier verdict is held back until a new check runs.
- Not checked yetcites [19] Janssen I, Baumgartner RN, Ross R, Rosenberg IH, Roubenoff R. Skel- etal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004;159:413-21. source
Checked before — its earlier verdict is held back until a new check runs.
- Could not verifycites [20] Gosker HR, Engelen MP, van Mameren H, et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002;76:113-9. sourceExperimental — accuracy not yet measured
Our copy of Gosker et al. (2002) only uses BIA as one of two ways to determine fat-free mass (Methods, 'Assessment of body composition': single-frequency 50 kHz BIA with the disease-specific equation of Schols et al, ref 13) and reports that FFM_BIA correlated with total mean fiber cross-sectional area in the COPD patients (Results/'3-5' passage and Figure 3, r = 0.87, P < 0.001). No passage in our copy evaluates or states that BIA is a useful clinical screening instrument, nor does it use the notion of a 'tissue-depletion pattern' or generalize beyond its 15 stable COPD patients versus 15 controls (Study population). Searched: 'bioelectrical impedance analysis useful clinical screening instrument tissue depletion chronic lung disease', 'FFM BIA validity comparison DXA', 'screening instrument tissue depletion pattern chronic lung disease', 'discussion BIA fat-free mass muscle mass loss wasting clinical implications' — none returned a statement on BIA's screening utility. The validating comparison of BIA with deuterium dilution is credited elsewhere in the reference list (Schols et al. 1991, ref 13), but our copy does not attribute the screening-instrument conclusion to it, so this is not misattribution on our evidence. (LLM, conf=0.62)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not checked yet
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Cachexia was significantly (P ҃ 0.001) more prevalent in GOLD stage IV than in GOLD stages II and III.”
- Also stated in: § Abstract · plain
“Semistarvation and muscle atrophy were equally distributed among disease stages, but the highest prevalence of cachexia was seen in GOLD stage IV.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an associationn = 412- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
None of the sources cited for this claim have been checked yet.
In the paper
“In line with that study, male patients in the current study were at higher risk of physical disability than were female patients.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Univariate analysis showed that low BMI, FFMI, and FMI were significantly associated with increased mortality risk (Table 3).”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Forty-six percent of the patients (n ҃ 189) died during a maximum follow-up of 5 y.”
- Also stated in: § 6 x Ȁ SD (all such values). · plain
“The mean duration of follow-up was 48 Ȁ 20 mo, during which time 46% of the patients died.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > Abstract
plainn = 189- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 6 x Ȁ SD (all such values). · plain
32 more claims
Create a free account to see all 63 claims and to verify the 42 references still open.
- It may state two separate claims as one. 16
- Probably not a substantial claim. 13
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.23”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > 6 x Ȁ SD (all such values).
“1.68, 2.24; NS”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“Mean FFMI in categories 2 and 4 was within median range (50th percentile) except for male patients in category 2, whose values were below the 10th percentile.”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“4: No impairment (n ҃ 55) | 59 | 17.6 Ȁ 2.2 | 90th”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > DISCUSSION
“physical disability risk was clearly lower in categories 3 and 4”
§ Body composition and mortality in chronic obstructive pulmonary disease 1,2 > RESULTS
“significantly (P 0.001) more patients were at moderate to high risk of disability in the cachexia and muscle atrophy categories (ie, 1 and 3) than in semistarvation and noimpairment categories (ie, 2 and 4)”
Citations
Cites
Celli, B. R., Cote, C. G., Marin, J. M., Casanova, C., Montes de Oca, M., Mendez, R. A., Pinto Plata, V., & Cabral, H. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021322 · Cited by 4,015 · cited 1×
“On the basis of numerous reports showing an association between BMI and mortality risk in COPD, Celli at al (26) recently proposed that clinical staging for COPD should be based not only on spirometry and resting arterial blood gases, eg, the recent GOLD criteria, but also on BMI, exercise capacity, and dyspnea score.”
BackgroundAssessment of fat-free mass using bioelectrical impedance measurements of the human body
Lukaski, H., Johnson, P., Bolonchuk, W., & Lykken, G. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/41.4.810 · Cited by 1,896 · cited 1×
“Bioelectrical impedance analysis (BIA) is an easy, safe, noninvasive, and convenient method of measuring the lean and fat body compartments (11).”
MethodEstimation of skeletal muscle mass by bioelectrical impedance analysis
Janssen, I., Heymsfield, S. B., Baumgartner, R. N., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.2.465 · Cited by 1,482
Skeletal Muscle Cutpoints Associated with Elevated Physical Disability Risk in Older Men and Women
Janssen, I. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh058 · Cited by 1,190
Weight Loss Is a Reversible Factor in the Prognosis of Chronic Obstructive Pulmonary Disease
SCHOLS, A. M. W. J., SLANGEN, J., VOLOVICS, L., & WOUTERS, E. F. M. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.6.9705017 · Cited by 1,085
Self-citationPrognostic Value of Nutritional Status in Chronic Obstructive Pulmonary Disease
LANDBO, C., PRESCOTT, E., LANGE, P., VESTBO, J., & ALMDAL, T. P. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9902115 · Cited by 1,033
Marquis, K., Debigaré, R., Lacasse, Y., LeBlanc, P., Jobin, J., Carrier, G., & Maltais, F. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2107031 · Cited by 844
Schols, A. M. W. J., Soeters, P. B., Dingemans, A. M. C., Mostert, R., Frantzen, P. J., & Wouters, E. F. M. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.5.1151 · Cited by 725
Self-citationFat-free mass index and fat mass index percentiles in Caucasians aged 18–98 y
Schutz, Y., Kyle, U., & Pichard, C. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802037 · Cited by 670
Schols, A. M., Soeters, P. B., Mostert, R., Pluymers, R. J., & Wouters, E. F. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.4.7551381 · Cited by 463
Self-citation
Cited by
Items 101–200 of 898
Wong, C. J. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.01.012 · Cited by 115
Ultrasound assessment of lower limb muscle mass in response to resistance training in COPD
Menon, M. K., Houchen, L., Harrison, S., Singh, S. J., Morgan, M. D., & Steiner, M. C. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-119 · Cited by 100
van den Borst, B., Koster, A., Yu, B., Gosker, H. R., Meibohm, B., Bauer, D. C., Kritchevsky, S. B., Liu, Y., Newman, A. B., Harris, T. B., et al. (2011) · Thorax · doi:10.1136/thoraxjnl-2011-200010 · Cited by 94
Self-citationAnorexia in chronic obstructive pulmonary disease — Association to cachexia and hormonal derangement
Koehler, F., Doehner, W., Hoernig, S., Witt, C. C., Anker, S. D., & John, M. (2006) · International Journal of Cardiology · doi:10.1016/j.ijcard.2006.07.088 · Cited by 110
Pison, C. M., Cano, N. J., Cherion, C., Caron, F., Court-Fortune, I., Antonini, M.-T., Gonzalez-Bermejo, J., Meziane, L., Molano, L. C., Janssens, J.-P., et al. (2011) · Thorax · doi:10.1136/thx.2010.154922 · Cited by 93
Hypercapnia in COPD: Causes, Consequences, and Therapy
Csoma, B., Vulpi, M. R., Dragonieri, S., Bentley, A. M., Felton, T., Lázár, Z., & Bikov, A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113180 · Cited by 108
Rutten, E. P. A., Franssen, F. M. E., ENGELEN, M. P. K. J., Wouters, E. F. �., Deutz, N. E. P., & Schols, A. M. W. J. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.4.829 · Cited by 106
Self-citationPresent and future utility of computed tomography scanning in the assessment and management of COPD
Ostridge, K., & Wilkinson, T. M. A. (2016) · European Respiratory Journal · doi:10.1183/13993003.00041-2016 · Cited by 106
Suzuki, Y., Yoshimura, K., Enomoto, Y., Yasui, H., Hozumi, H., Karayama, M., Furuhashi, K., Enomoto, N., Fujisawa, T., Nakamura, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-32478-z · Cited by 104
Health Benefits of Long-Term Weight-Loss Maintenance
Rueda-Clausen, C. F., Ogunleye, A. A., & Sharma, A. M. (2015) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071714-034434 · Cited by 91
Abdulai, R. M., Jensen, T. J., Patel, N. R., Polkey, M. I., Jansson, P., Celli, B. R., & Rennard, S. I. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201703-0615ci · Cited by 91
Ramos, E. M. C., de Toledo, A. C., Fosco, L. C., Bonfim, R., Bertolini, G. N., Guarnier, F. A., Cecchini, R., Pastre, C. M., Langer, D., Gosselink, R., et al. (2014) · Clinical Rehabilitation · doi:10.1177/0269215514527842 · Cited by 100
Calder, P. C., Laviano, A., Lönnqvist, F., Muscaritoli, M., Öhlander, M., & Schols, A. M. W. J. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12228 · Cited by 100
Self-citationRecommendations for epidemiological studies on COPD
Quanjer, P. H., Stanojevic, S., Swanney, M. P., & Miller, M. R. (2012) · European Respiratory Journal · doi:10.1183/09031936.00224411 · Cited by 100
King, S., Nyulasi, I. B., Strauss, B. J., Kotsimbos, T. C., Bailey, M., & Wilson, J. W. (2009) · Nutrition · doi:10.1016/j.nut.2009.06.026 · Cited by 99
Romme, E. A., Rutten, E. P. A., Smeenk, F. W. J. M., Spruit, M. A., Menheere, P. P. C. A., & Wouters, E. F. �. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.671536 · Cited by 97
Self-citationFrailty in Pulmonary and Critical Care Medicine
Singer, J. P., Lederer, D. J., & Baldwin, M. R. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201512-833fr · Cited by 97
Sarcopenia Associated with Chronic Obstructive Pulmonary Disease
Kim, S. H., Shin, M., Shin, Y. B., & Kim, K. U. (2019) · Journal of Bone Metabolism · doi:10.11005/jbm.2019.26.2.65 · Cited by 97
Spruit, M. A., Pennings, H.-J., Janssen, P. P., Does, J. D., Scroyen, S., Akkermans, M. A., Mostert, R., & Wouters, E. F. M. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.07.003 · Cited by 89
Self-citationOsteoporosis in Chronic Obstructive Pulmonary Disease
Sarkar, M. S., Bhardwaj, R., Madabhavi, I., & Khatana, J. (2015) · Clinical Medicine Insights Circulatory Respiratory and Pulmonary Medicine · doi:10.4137/ccrpm.s22803 · Cited by 98
Fat-Free Mass Index for Evaluating the Nutritional Status and Disease Severity in COPD
Luo, Y., Zhou, L., Li, Y., Guo, S., Li, X., Zheng, J., Zhu, Z., Chen, Y., Huang, Y., Chen, R., et al. (2016) · Respiratory Care · doi:10.4187/respcare.04358 · Cited by 97
Musculoskeletal Disorders in Chronic Obstructive Pulmonary Disease
Cielen, N., Maes, K., & Gayan‐Ramirez, G. (2014) · BioMed Research International · doi:10.1155/2014/965764 · Cited by 99
The clinical management in extremely severe COPD
Ambrosino, N., & Simonds, A. K. (2007) · Respiratory Medicine · doi:10.1016/j.rmed.2007.02.011 · Cited by 97
Structural alterations of skeletal muscle in copd
Mathur, S., Brooks, D., & Carvalho, C. R. F. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00104 · Cited by 97
Wouters, E. F. �., Posthuma, R., Koopman, M., Liu, W.-Y., Sillen, M. J. H., Hajian, B., Sastry, M., Spruit, M. A., & Franssen, F. M. E. (2020) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2020.1700796 · Cited by 94
Self-citationCellular interplay in skeletal muscle regeneration and wasting: insights from animal models
Henrot, P., Blervaque, L., Dupin, I., Zysman, M., Estèves, P., Gouzi, F., Hayot, M., Pomiès, P., & Berger, P. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13103 · Cited by 94
van Venrooij, L. M. W., Verberne, H. J., de Vos, R., Borgmeijer-Hoelen, M. M. M. J., van Leeuwen, P. A. M., & de Mol, B. A. J. M. (2011) · Nutrition · doi:10.1016/j.nut.2011.02.007 · Cited by 94
Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD
van de Bool, C., Rutten, E. P. A., Franssen, F. M. E., Wouters, E. F. �., & Schols, A. M. W. J. (2015) · European Respiratory Journal · doi:10.1183/09031936.00197314 · Cited by 93
Self-citationRutten, E. P. A., Calverley, P. M. A., Casaburi, R. H., Agustí, A. G. N., Bakke, P. S., Celli, B. R., Coxson, H. O., Crim, C. C., Lomas, D. A., MacNee, W., et al. (2013) · Annals of Nutrition and Metabolism · doi:10.1159/000353211 · Cited by 93
Self-citationNutritional Aspects of Chronic Obstructive Pulmonary Disease
King, D. A., Cordova, F., & Scharf, S. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200707-092et · Cited by 92
“In the prospective trial, four groups were treated for 8 weeks: (1) no treatment, (2) nutritional support, (3) androgen treatment, and (4) both nutritional support and androgen treatment.”
BackgroundMethodInfluentialZapatero, A., Barba, R., Ruiz, J. R., Losa, J. E., Plaza, S., Canora, J., & Marco, J. (2013) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12088 · Cited by 92
miR‐424‐5p reduces ribosomal RNA and protein synthesis in muscle wasting
Connolly, M., Paul, R., Garros, R. F., Natanek, S. A., Bloch, S. A. A., Lee, J. Y., Lorenzo, J. P., Patel, H. P., Cooper, C. C., Sayer, A. A., et al. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12266 · Cited by 92
Wada, H., Ikeda, A., Maruyama, K., Yamagishi, K., Barnes, P. J., Tanigawa, T., Tamakoshi, A., & Iso, H. (2021) · Scientific Reports · doi:10.1038/s41598-020-79860-4 · Cited by 93
Güell, M. R., Lobato, S. D., Trigo, G. R., Vélez, F. M., Miguel-Pagola, M. S., Cejudo, P., Ruiz, F. Ó., Muñoz, A., Iturri, J. B. G., García, A., et al. (2014) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2014.02.014 · Cited by 92
Meyer, A., Zoll, J., Charles, A. L., Charloux, A., de Blay, F., Diemunsch, P., Sibilia, J., Piquard, F., & Geny, B. (2013) · Experimental Physiology · doi:10.1113/expphysiol.2012.069468 · Cited by 90
Song, X., Dou, X., Chang, J., Zeng, X., Xu, Q., & Xu, C. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2414805 · Cited by 90
Jonker, R., Deutz, N. E. P., Erbland, M. L., ANDERSON, P. J., & ENGELEN, M. P. K. J. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.06.014 · Cited by 89
Body mass index, weight change and mortality risk in a prospective study in India
Sauvaget, C., Ramadas, K., Thomas, G., Vinoda, J., Thara, S., & Sankaranarayanan, R. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn059 · Cited by 84
Skeletal Muscle Molecular Responses to Resistance Training and Dietary Supplementation in COPD
Constantin, D., Menon, M. K., Houchen-Wolloff, L., Morgan, M. D., Singh, S. J., Greenhaff, P., & Steiner, M. C. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202764 · Cited by 88
Rabinovich, R. A., Drost, E., Manning, J. R., Dunbar, D. R., Díaz-Ramos, M., Lakhdar, R., Bastos, R., & MacNee, W. (2015) · Respiratory Research · doi:10.1186/s12931-014-0139-5 · Cited by 88
Bak, S. H., Kwon, S. O., Han, S., & Kim, W. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1191-y · Cited by 88
Nyberg, A., Saey, D., & Maltais, F. (2015) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201505-278ps · Cited by 88
Nutritional supplementation in patients with chronic obstructive pulmonary disease
Hsieh, M., Yang, T., & Tsai, Y. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2015.10.008 · Cited by 88
ESPEN Guidelines on Parenteral Nutrition: On Cardiology and Pneumology
Anker, S. D., Laviano, A., Filippatos, G. S., John, M., Paccagnella, A., Ponikowski, P. P., & Schols, A. M. W. J. (2009) · Clinical Nutrition · doi:10.1016/j.clnu.2009.04.023 · Cited by 87
Self-citationvan der Velden, J. L. J., Schols, A. M. W. J., Willems, J., KELDERS, M. C. J. M., & LANGEN, R. C. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707812200 · Cited by 87
Self-citationFat‐free mass index predicts survival in patients with idiopathic pulmonary fibrosis
Nishiyama, O., Yamazaki, R., Sano, H., Iwanaga, T., Higashimoto, Y., Kume, H., & Tohda, Y. (2016) · Respirology · doi:10.1111/resp.12941 · Cited by 87
Sava, F., Laviolette, L., Bernard, S., Breton, M.-J., Bourbeau, J., & Maltais, F. (2010) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-10-55 · Cited by 84
Myostatin: Basic biology to clinical application
Esposito, P. B., Picciotto, D., Battaglia, Y., Costigliolo, F., Viazzi, F. C., & Verzola, D. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.09.006 · Cited by 83
Chronic Obstructive Pulmonary Disease: An Update on Diagnosis and Management Issues in Older Adults
Nazir, S. A., & Erbland, M. L. (2009) · Drugs & Aging · doi:10.2165/11316760-000000000-00000 · Cited by 83
Zhang, M., Tang, J., Li, Y., Xie, Y., Shan, H., Chen, M., Zhang, J., Yang, X., Zhang, Q., & Yang, X. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.09.018 · Cited by 79
Kwan, H. Y., Maddocks, M., Nolan, C. M., Jones, S. E., Patel, S., Barker, R. E., Kon, S. S. C., Polkey, M. I., Cullinan, P., & Man, W. D. ‐. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12463 · Cited by 80
Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease
Kida, K., Furutate, R., Ishii, I., Wakabayashi, Motegi, Yamada, & Gemma (2011) · International Journal of COPD · doi:10.2147/copd.s22885 · Cited by 82
Skeletal Muscle Abnormalities in Pulmonary Arterial Hypertension
Breda, A. P., de Albuquerque, A. L. P., Jardim, C., Morinaga, L. T. K., Suesada, M., Fernandes, C. J. C. D. S., Dias, B., Lourenço, R. B., Salge, J. M., & Souza, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114101 · Cited by 82
Gilligan, L. A., Towbin, A. J., Dillman, J. R., Somasundaram, E., & Trout, A. T. (2019) · Pediatric Radiology · doi:10.1007/s00247-019-04562-7 · Cited by 82
Comparative assessment of the quadriceps and the diaphragm in patients with COPD
Caron, M.-A., Debigaré, R., Dekhuijzen, P. N. R., & Maltais, F. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00194.2009 · Cited by 69
Sabino, P. G., Silva, B. M., & Brunetto, A. F. (2010) · Clinics · doi:10.1590/s1807-59322010000600007 · Cited by 80
Co-morbidities of COPD in primary care: frequency, relation to COPD, and treatment consequences
van der Molen, T. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00053 · Cited by 80
Physical activity, nutritional status and systemic inflammation in COPD
Laveneziana, P., & Palange, P. (2012) · European Respiratory Journal · doi:10.1183/09031936.00041212 · Cited by 81
Muscle loss contributes to higher morbidity and mortality in COPD : An analysis of national trends
Attaway, A. H., Welch, N., Hatipoglu, U. S., Zein, J., & Dasarathy, S. (2020) · Respirology · doi:10.1111/resp.13877 · Cited by 79
Bolton, C. E., Stone, M., Edwards, P. H., Duckers, J. M., Evans, W. D., & Shale, D. (2009) · Chronic Respiratory Disease · doi:10.1177/1479972309103131 · Cited by 79
Bolton, C. E., Broekhuizen, R., Ionescu, A. A., Nixon, L. S., Wouters, E. F. M., Shale, D. J., & Schols, A. M. W. J. (2007) · Thorax · doi:10.1136/thx.2006.060368 · Cited by 67
Self-citationGeneric, symptom based, exercise rehabilitation; integrating patients with COPD and heart failure
Evans, R. A., Singh, S., Collier, R., Loke, I. W., STEINER, M. C., & Morgan, M. D. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.04.024 · Cited by 79
Critical view on diagnosing muscle wasting by single-frequency bio-electrical impedance in COPD
Rutten, E. P. A., Spruit, M. A., & Wouters, E. F. �. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.07.004 · Cited by 78
Self-citationKelm, D. J., Bonnes, S. L., Jensen, M. D., Eiken, P. W., Hathcock, M. A., Kremers, W. K., & Kennedy, C. C. (2016) · Clinical Transplantation · doi:10.1111/ctr.12683 · Cited by 73
Chest computed tomography-derived low fat-free mass index and mortality in COPD
McDonald, M., Díaz, A. A., Rutten, E. P. A., Lutz, S. M., Harmouche, R., Estépar, R. S. J., Kinney, G. L., Hokanson, J. E., Gower, B. A., Wouters, E. F. �., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.01134-2017 · Cited by 79
Self-citationFactors Limiting Exercise Tolerance in Chronic Lung Diseases
Vogiatzis, I., & Zakynthinos, S. (2012) · Comprehensive Physiology · doi:10.1002/cphy.c110015 · Cited by 77
“to carry out activities of daily living are a hallmark of have been identified as factors related to adverse prognosis (48,208,281).”
Luna, N. M., Orea‐Tejeda, A., González‐Islas, D., Flores‐Cisneros, L., Keirns‐Davis, C., Sánchez‐Santillán, R., García, I. P., Ayala, Y. R. G., Martínez-Vázquez, V., & Reyna, Ó. U. M. (2022) · BMC Pulmonary Medicine · doi:10.1186/s12890-022-01907-1 · Cited by 78
van Venrooij, L. M. W., de Vos, R., Zijlstra, E., Borgmeijer-Hoelen, M. M. M. J., van Leeuwen, P. A. M., & de Mol, B. A. J. M. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.07.033 · Cited by 77
Nutrition impact symptoms and body composition in patients with COPD
Nordén, J., Grönberg, A., Bosaeus, I. G., Forslund, H. B., Hulthén, L., Rothenberg, E. M., Karlsson, J., Wallengren, O., & Slinde, F. (2014) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2014.76 · Cited by 77
Raju, S. V., Solomon, G. M., Dransfield, M. T., & Rowe, S. M. (2015) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2015.11.003 · Cited by 77
Muscle-specific GSK-3β ablation accelerates regeneration of disuse-atrophied skeletal muscle
Pansters, N. A. M., Schols, A. M. W. J., Verhees, K. J. P., de Theije, C. C., Snepvangers, F. J. M., KELDERS, M. C. J. M., Ubags, N. D. J., Haegens, A., & LANGEN, R. C. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.006 · Cited by 78
Self-citationGurgun, A., Deniz, S., Argın, M., & Karapolat, H. (2013) · Respirology · doi:10.1111/resp.12019 · Cited by 63
Sarcopenia and Short-Term Outcomes After Esophagectomy: A Meta-analysis
Wang, P., Xu, L., Chen, X., Xu, L., Yu, Y., Zhang, R., Sun, H., Wu, H., & Li, Y. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-08236-9 · Cited by 76
Guler, S. A., Hur, S. A., Lear, S. A., Camp, P. G., & Ryerson, C. J. (2019) · Respiratory Research · doi:10.1186/s12931-019-1019-9 · Cited by 76
Towards Personalized Management of Sarcopenia in COPD
van Bakel, S. I. J., Gosker, H. R., LANGEN, R. C. J., & Schols, A. M. W. J. (2021) · International Journal of COPD · doi:10.2147/copd.s280540 · Cited by 75
Self-citationAnnegarn, J., Spruit, M. A., Uszko‐Lencer, N. H. M. K., Vanbelle, S., Savelberg, H. H. C. M., Schols, A. M. W. J., Wouters, E. F. �., & Meijer, K. (2011) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2011.06.021 · Cited by 75
Self-citationAn exploration of factors predicting malnutrition in patients with advanced head and neck cancer
Silander, E. M., Nyman, J., & Hammerlid, E. B. (2013) · The Laryngoscope · doi:10.1002/lary.23877 · Cited by 75
Jouneau, S., Kerjouan, M., Rousseau, C., Léderlin, M., Llamas‐Gutierrez, F., Latour, B. R. D., Guillot, S., Vernhet, L., Desrues, B., & Thibault, R. (2018) · Nutrition · doi:10.1016/j.nut.2018.12.008 · Cited by 75
Sintomas indicativos de disfagia em portadores de DPOC
Chaves, R. D. D., Carvalho, C. R. F., Cukier, A., Stelmach, R., & de Andrade, C. R. F. (2011) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132011000200007 · Cited by 74
Attaway, A. H., Zein, J., & Hatipoglu, U. S. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100515 · Cited by 74
Abdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary disease
Rutten, E. P. A., Breyer, M., Spruit, M. A., Hofstra, T., van Melick, P. P. M. J., Schols, A. M. W. J., & Wouters, E. F. �. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.04.007 · Cited by 74
Self-citationMuscle atrophy in aging and chronic diseases: is it sarcopenia or cachexia?
Muscaritoli, M., Lucia, S., Molfino, A., Cederholm, T., & Fanelli, F. R. (2012) · Internal and Emergency Medicine · doi:10.1007/s11739-012-0807-8 · Cited by 76
Bucholz, E. M., Krumholz, H. A., & Krumholz, H. M. (2016) · PLoS Medicine · doi:10.1371/journal.pmed.1001998 · Cited by 71
Dal Negro, R. W., Aquilani, R., Bertacco, S., Boschi, F., Micheletto, C., & Tognella, S. (2016) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2010.310 · Cited by 70
Yang, L., Zhou, M., Smith, M. C., Yang, G., Peto, R., Wang, J., Boreham, J., Hu, Y., & Chen, Z. (2010) · International Journal of Epidemiology · doi:10.1093/ije/dyq051 · Cited by 70
Etheridge, T., Atherton, P. J., Wilkinson, D., Selby, A., Rankin, D., Webborn, N., Smith, K., & Watt, P. W. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00276.2011 · Cited by 61
Faganello, M. M., Tanni, S. É., Pelegrino, N. R. G., Lucheta, P. A., Godoy, I., & Sanchez, F. F. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181bb8111 · Cited by 69
Ingadóttir, Á. R., Beck, A. M., Baldwin, C., Weekes, C. E., Geirsdóttir, Ó. G., Ramel, A., Gíslason, Þ., & Gunnarsdóttir, I. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.05.031 · Cited by 69
Kao, C. C., Hsu, J. W.-C., Bandi, V., Hanania, N. A., Kheradmand, F., & Jahoor, F. (2011) · Metabolism · doi:10.1016/j.metabol.2011.02.013 · Cited by 69
Muscle training with repetitive magnetic stimulation of the quadriceps in severe COPD patients
Bustamante, V., María, E. L. D. S., Gorostiza, A., Jiménez, U., & Gáldiz, J. B. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.10.001 · Cited by 69
Body composition and sarcopenia in patients with chronic obstructive pulmonary disease
Costa, T. M. D. R. L., Costa, F. M., Jonasson, T. H., Moreira, C. A., Boguszewski, C. L., & Borba, V. Z. C. (2018) · Endocrine · doi:10.1007/s12020-018-1533-4 · Cited by 68
Pectoralis muscle area and mortality in smokers without airflow obstruction
Díaz, A. A., Martinez, C. H., Harmouche, R., Young, T. P., McDonald, M., Ross, J. C., Han, M. L. K., Bowler, R. P., Make, B. J., Regan, E. A., et al. (2018) · Respiratory Research · doi:10.1186/s12931-018-0771-6 · Cited by 68
Laviano, A., Gori, C. S., & Rianda, S. (2014) · Advances in food and nutrition research · doi:10.1016/b978-0-12-800270-4.00003-1 · Cited by 68
Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease
Wan, E. S., Cho, M. H., Boutaoui, N., Klanderman, B. J., Sylvia, J. S., Ziniti, J. P., Won, S., Lange, C., Pillai, S. G., Anderson, W. H., et al. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0294oc · Cited by 67
Self-citationIncidence of pulmonary embolism during COPD exacerbation
Akpınar, E. E., Hoşgün, D., Akpynar, S., Ataç, G. K., Erdoğan, B. D., & Gülhan, M. (2014) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132014000100006 · Cited by 67
Obesity and Chronic Obstructive Pulmonary Disease: Is Fatter Really Better?
Galesanu, R. G., Bernard, S., Marquis, K., Lacasse, Y., Poirier, P., Bourbeau, J., & Maltais, F. (2014) · Canadian Respiratory Journal · doi:10.1155/2014/181074 · Cited by 66
Blasio, F. D., Santaniello, M., Blasio, F. D., Mazzarella, G., Bianco, A., Lionetti, L., Franssen, F. M. E., & Scalfi, L. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.147 · Cited by 66
Ng, W. L., Collins, P. F., Hickling, D. F., & Bell, J. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.10.025 · Cited by 65
Does physical inactivity cause chronic obstructive pulmonary disease?
Hopkinson, N. S., & Polkey, M. I. (2010) · Clinical Science · doi:10.1042/cs20090458 · Cited by 65
Chest CT Measures of Muscle and Adipose Tissue in COPD
Díaz, A. A., Zhou, L., Young, T., McDonald, M., Harmouche, R., Ross, J. C., Estépar, R. S. J., Wouters, E. F. �., Coxson, H. O., MacNee, W., et al. (2014) · Academic Radiology · doi:10.1016/j.acra.2014.05.013 · Cited by 65
Self-citation
Metadata
- Authors
- Schols, A. M., Broekhuizen, R., Weling-Scheepers, C. A., & Wouters, E. F.
- Affiliations
- Maastricht University (NL)
- Corresponding author
- Schols, Annemie MWJ
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2005-07
- Volume
- 82
- Issue
- 1
- Pages
- 53-59
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2150051820
- Cited by
- 902
- References
- 35
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 34 · 2023: 44 · 2022: 41 · 2021: 47 · 2020: 49 · 2019: 49 · 2018: 45 · 2017: 45 · 2016: 60 · 2015: 57 · 2014: 61 · 2013: 55 · 2012: 37
- FWCI
- 19.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 6456 d)
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Research Publications (Maastricht University) (publishedVersion, other-oa)
- Research Publications (Maastricht University) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- chronic obstructive pulmonary disease, body composition, mortality, fat-free mass index, fat mass index, skeletal muscle index, cachexia, muscle atrophy, semistarvation, disease severity
- MeSH terms
- Body Composition, Body Weight, Cachexia, Female, Humans, Male, Middle Aged, Reference Values, Respiratory Function Tests, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-19, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-19 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.